Company overview
Leon Nanodrugs is a Munich-based technology provider specializing in nanoparticle-based drug manufacturing equipment and services. The company offers proprietary FR-JET mixing reactor systems and a portfolio of devices (NANOlab, NANOme, NANOus) that enable seamless scaling from R&D to GMP-compliant commercial manufacturing. Leon's platform supports nanoencapsulation of active pharmaceutical ingredients, RNA-based lipid nanoparticles, and genetic material delivery systems, with integrated aseptic processing for personalized and commercial-scale production.
Nanoencapsulation Manufacturing Equipment is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing partner serving United States & Americas. Core focus areas include nanoencapsulation equipment, lipid nanoparticles, gmp manufacturing, pharmaceutical equipment, drug delivery systems.
Industry categories: CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Nanoencapsulation Manufacturing Equipment include Equipment — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://leon-nanodrugs.com
- Categories
- CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- nanoencapsulation equipment, lipid nanoparticles, gmp manufacturing, pharmaceutical equipment, drug delivery systems
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What manufacturing scales does Leon support?
- Leon's equipment portfolio covers lab-scale screening, clinical studies, and commercial GMP manufacturing. The NANOlab device is optimized for early-stage research and screening, while NANOme and NANOus systems enable GMP-compliant aseptic manufacturing at both individualized and commercial production scales.
- What is Leon's core technology platform?
- Leon's proprietary FR-JET mixing reactor is the centerpiece of their technology platform. It enables modular, flexible nanoencapsulation with seamless transition from R&D to commercial-scale manufacturing, eliminating common tech transfer challenges between development and production scales.
- What types of drug substances can Leon's systems encapsulate?
- Leon's nanoparticle-based drug delivery systems support encapsulation of active pharmaceutical ingredients (APIs), RNA-based lipid nanoparticles (LNPs), genetic material, and other therapeutic substances. The technology enhances bioavailability, solubility, and stability of formulations.
- Does Leon offer manufacturing services or only equipment?
- Leon provides both equipment and services. Beyond manufacturing equipment, Leon offers nanoencapsulation development services and end-to-end nano-medicine development support through partnerships with pharmaceutical companies and contract manufacturers.
- What regulatory compliance features are built into Leon's systems?
- Leon's NANOme and NANOus systems feature fully GMP-compliant, closed, and automated aseptic processing with single-use sterile fluid paths. Integrated in-process controls and built-in aseptic conditions ensure high product quality and enable rapid, contamination-free back-to-back manufacturing.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
